Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-064261

Chief Financial Officer sold 4,398 shares at $13.62 ($59,901)

From the SEC's structured data for this filing

Trades in this filing

Fenton Mary Kay · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-20 Sale : show line 1 in the form −4,398 $13.62 $59,901 126,380 D
Open-market sales · 4,398 sh · avg $13.62 · $59,901
Loading xslF345X05/ownership.xml…